Fluorescent kinase probes enabling identification and dynamic imaging of HER2(+) Cells

Heajin Lee, Wenjun Liu, Adrienne S. Brown, Ralf Landgraf, James N Wilson

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The human epidermal growth factor receptor, EGFR/ ERBB/HER, family of receptor tyrosine kinases is central to many signaling pathways and a validated chemotherapy target in multiple cancers. While EGFR/ERBB-targeted therapies, including monoclonal antibodies, e.g., trastuzumab, and small molecule kinase inhibitors, such as lapatinib, have been developed, rapid identification and classification of cancer cells is key to identifying the best treatment regime. We report ERBB2 (also HER2) targeting kinase probes that exhibit a "turn-on" emission response upon binding. These live cell compatible probes differentiate ERBB2(+) cells from low-level, ERBB2(-) cells by targeting the intracellular ATP-binding pocket of ERBB2 with therapeutic inhibitor-like specificity. Beyond kinase expression levels, probe signal is linked to the phosphotyrosine-correlated activation state of the ERBB2 population. Additionally, the rapid signaling capability of the probes can report changes in activation state in live cells providing a unique type of complementary information to immunohistochemical assays of receptor kinase populations.

Original languageEnglish (US)
Pages (from-to)11310-11313
Number of pages4
JournalAnalytical Chemistry
Volume88
Issue number23
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Phosphotransferases
Imaging techniques
Chemical activation
Phosphotyrosine
Chemotherapy
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Assays
Adenosine Triphosphate
Monoclonal Antibodies
Cells
Molecules

ASJC Scopus subject areas

  • Analytical Chemistry

Cite this

Fluorescent kinase probes enabling identification and dynamic imaging of HER2(+) Cells. / Lee, Heajin; Liu, Wenjun; Brown, Adrienne S.; Landgraf, Ralf; Wilson, James N.

In: Analytical Chemistry, Vol. 88, No. 23, 01.01.2016, p. 11310-11313.

Research output: Contribution to journalArticle

Lee, Heajin ; Liu, Wenjun ; Brown, Adrienne S. ; Landgraf, Ralf ; Wilson, James N. / Fluorescent kinase probes enabling identification and dynamic imaging of HER2(+) Cells. In: Analytical Chemistry. 2016 ; Vol. 88, No. 23. pp. 11310-11313.
@article{742d16348e1b4f1cb75494943a2b2d42,
title = "Fluorescent kinase probes enabling identification and dynamic imaging of HER2(+) Cells",
abstract = "The human epidermal growth factor receptor, EGFR/ ERBB/HER, family of receptor tyrosine kinases is central to many signaling pathways and a validated chemotherapy target in multiple cancers. While EGFR/ERBB-targeted therapies, including monoclonal antibodies, e.g., trastuzumab, and small molecule kinase inhibitors, such as lapatinib, have been developed, rapid identification and classification of cancer cells is key to identifying the best treatment regime. We report ERBB2 (also HER2) targeting kinase probes that exhibit a {"}turn-on{"} emission response upon binding. These live cell compatible probes differentiate ERBB2(+) cells from low-level, ERBB2(-) cells by targeting the intracellular ATP-binding pocket of ERBB2 with therapeutic inhibitor-like specificity. Beyond kinase expression levels, probe signal is linked to the phosphotyrosine-correlated activation state of the ERBB2 population. Additionally, the rapid signaling capability of the probes can report changes in activation state in live cells providing a unique type of complementary information to immunohistochemical assays of receptor kinase populations.",
author = "Heajin Lee and Wenjun Liu and Brown, {Adrienne S.} and Ralf Landgraf and Wilson, {James N}",
year = "2016",
month = "1",
day = "1",
doi = "10.1021/acs.analchem.6b03836",
language = "English (US)",
volume = "88",
pages = "11310--11313",
journal = "Analytical Chemistry",
issn = "0003-2700",
publisher = "American Chemical Society",
number = "23",

}

TY - JOUR

T1 - Fluorescent kinase probes enabling identification and dynamic imaging of HER2(+) Cells

AU - Lee, Heajin

AU - Liu, Wenjun

AU - Brown, Adrienne S.

AU - Landgraf, Ralf

AU - Wilson, James N

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The human epidermal growth factor receptor, EGFR/ ERBB/HER, family of receptor tyrosine kinases is central to many signaling pathways and a validated chemotherapy target in multiple cancers. While EGFR/ERBB-targeted therapies, including monoclonal antibodies, e.g., trastuzumab, and small molecule kinase inhibitors, such as lapatinib, have been developed, rapid identification and classification of cancer cells is key to identifying the best treatment regime. We report ERBB2 (also HER2) targeting kinase probes that exhibit a "turn-on" emission response upon binding. These live cell compatible probes differentiate ERBB2(+) cells from low-level, ERBB2(-) cells by targeting the intracellular ATP-binding pocket of ERBB2 with therapeutic inhibitor-like specificity. Beyond kinase expression levels, probe signal is linked to the phosphotyrosine-correlated activation state of the ERBB2 population. Additionally, the rapid signaling capability of the probes can report changes in activation state in live cells providing a unique type of complementary information to immunohistochemical assays of receptor kinase populations.

AB - The human epidermal growth factor receptor, EGFR/ ERBB/HER, family of receptor tyrosine kinases is central to many signaling pathways and a validated chemotherapy target in multiple cancers. While EGFR/ERBB-targeted therapies, including monoclonal antibodies, e.g., trastuzumab, and small molecule kinase inhibitors, such as lapatinib, have been developed, rapid identification and classification of cancer cells is key to identifying the best treatment regime. We report ERBB2 (also HER2) targeting kinase probes that exhibit a "turn-on" emission response upon binding. These live cell compatible probes differentiate ERBB2(+) cells from low-level, ERBB2(-) cells by targeting the intracellular ATP-binding pocket of ERBB2 with therapeutic inhibitor-like specificity. Beyond kinase expression levels, probe signal is linked to the phosphotyrosine-correlated activation state of the ERBB2 population. Additionally, the rapid signaling capability of the probes can report changes in activation state in live cells providing a unique type of complementary information to immunohistochemical assays of receptor kinase populations.

UR - http://www.scopus.com/inward/record.url?scp=85032869937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032869937&partnerID=8YFLogxK

U2 - 10.1021/acs.analchem.6b03836

DO - 10.1021/acs.analchem.6b03836

M3 - Article

C2 - 27934102

AN - SCOPUS:85032869937

VL - 88

SP - 11310

EP - 11313

JO - Analytical Chemistry

JF - Analytical Chemistry

SN - 0003-2700

IS - 23

ER -